Tnkase Kit
Product Images NDC 50242-120

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tnkase (NDC 50242-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B-d (1a9e312c F0b0 4139 B526 B904b80883a4 01)

FDA Label Image

Dual Cannula Device (1a9e312c F0b0 4139 B526 B904b80883a4 02)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
This is a description of TNKase, a medication used for myocardial infarction. The kit includes a 50mg vial of TNKase, a syringe, and water for injection. The vial of TNKase consists of Tenecteplase, L-arginine, phosphoric acid, and polysorbate 20. It is manufactured by Genentech and has a US License No.: 1048.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.